Abstract:
The invention provides a stable conjugate of a target cell binding protein, preferably an antibody, covalently linked to a biotin analog moiety for use in positive cell selection and release. Methods for positive cell selection and release using the stable conjugate are described.
Abstract:
The invention provides a nonenzymic method for the release of cells which have been selected from a heterogeneous cell suspension by antibody-mediated binding to beads or other solid support. The method entails forming within the cell suspension a complex comprising the solid support linked to a primary monoclonal antibody, which in turn is bound to a cell surface antigen on the target cells. The complex is separated from the cell suspension, and then contacted with a specific peptide which binds to the primary antibody, displacing the antibody from the cell surface antigen, thereby releasing the target cell from the complex. The invention also provides methods for positive/negative cell selection wherein target cells having a first antigen are selected from a heterogeneous cell suspension containing undesired cells having a second antigen.
Abstract:
The invention provides a nonenzymic method for the release of cells which have been selected from a heterogeneous cell suspension by antibody-mediated binding to beads or other solid support. The method entails forming within the cell suspension a complex comprising the solid support linked to a primary monoclonal antibody, which in turn is bound to a cell surface antigen on the target cells. The complex is separated from the cell suspension, and then contacted with a specific peptide which binds to the primary antibody, displacing the antibody from the cell surface antigen, thereby releasing the target cell from the complex. The invention also provides methods for positive/negative cell selection wherein target cells having a first antigen are selected from a heterogeneous cell suspension containing undesired cells having a second antigen.
Abstract:
The invention provides a non-enzymatic method for the release of cells which have beem positively selected from a heterogeneous cell suspension by antibody-mediated binding to beads or other solid support . The method entails forming within the cell suspension a complex comprising the solid support linked to a primary monoclonal antibody , which in tum is bound to a cell surface antigen on the target cells. The complex is separated from the cell suspension, and then contacted with a specific peptide which binds to the primary antibody, displacing the antibody from the cell surface antigen, thereby releasing the target cell from the complex. The invention also provides methods for positive/negative cell selection wherein target cells having a first antigen are selected from a heterogeneous cell suspension containing undesired cells having a second antigen. The invention also provides methods for identifying a specific peptide useful for the release of a target cell from the binding of a specific monoclonal antibody. The methods of the invention are particularly useful for the positive selection of CD34+ hematopoietic stem cells and the concomitant purging of undesired tumor cells or lymphocytes from the positively selected cell population. The purified CD34+ cell composition is then usefulfor reinfusion to a cancer patient after high-dose therapy in order to reconstitute the patient's immune system.
Abstract:
The invention provides a nonenzymic method for the release of cells which have been selected from a heterogeneous cell suspension by antibody-mediated binding to beads or other solid support. The method entails forming within the cell suspension a complex comprising the solid support linked to a primary monoclonal antibody, which in turn is bound to a cell surface antigen on the target cells. The complex is separated from the cell suspension, and then contacted with a specific peptide which binds to the primary antibody, displacing the antibody from the cell surface antigen, thereby releasing the target cell from the complex. The invention also provides methods for positive/negative cell selection wherein target cells having a first antigen are selected from a heterogeneous cell suspension containing undesired cells having a second antigen.
Abstract:
The invention provides a nonenzymic method for the release of cells which have been selected from a heterogeneous cell suspension by antibody-mediated binding to beads or other solid support. The method entails forming within the cell suspension a complex comprising the solid support linked to a primary monoclonal antibody, which in turn is bound to a cell surface antigen on the target cells. The complex is separated from the cell suspension, and then contacted with a specific peptide which binds to the primary antibody, displacing the antibody from the cell surface antigen, thereby releasing the target cell from the complex. The invention also provides methods for positive/negative cell selection wherein target cells having a first antigen are selected from a heterogeneous cell suspension containing undesired cells having a second antigen.
Abstract:
The invention provides a non-enzymatic method for the release of cells which have beem positively selected from a heterogeneous cell suspension by antibodymediated binding to beads or other solid support. The method entails forming within the cell suspension a complex comprising the solid support linked to a primary monoclonal antibody, which in turn is bound to a cell surface antigen on the target cells. The complex is separated from the cell suspension, and then contacted with a specific peptide which binds to the primary antibody, displacing the antibody from the cell surface antigen, thereby releasing the target cell from the complex. The invention also provides methods for positive/negative cell selection wherein target cells having a first antigen are selected from a heterogeneous cell suspension containing undesired cells having a second antigen. The invention also provides methods for identifying a specific peptide useful for the release of a target cell from the binding of a specific monoclonal antibody. The methods of the invention are particularly useful for the positive selection of CD34+ hematopoietic stem cells and the concomitant purging of undesired tumor cells or lymphocytes from the positively selected cell population. The purified CD34+ cell composition is then useful for reinfusion to a cancer patient after high-dose therapy in order to reconstitute the patient's immune system.
Abstract:
The invention provides a stable conjugate of a target cell binding protein, preferably an antibody, covalently linked to a biotin analog moiety for use in positive cell selection and release. The invention also provides a method for forming a stable conjugate of an antibody and a biotin analog moiety comprising bringing an N-hydroxysuccinimide (NHS) ester of a biotin analog into reactive contact with an antibody in a medium with a pH of about 8 and at a temperature of about 2.degree.-8.degree.C. The invention also provides methods for the positive selection of target cells from a heterogeneous cell suspension. One method involves the formation within the cell suspension of a complex formed by the target cell bound to a primary antibody linked to a biotin analog moiety, a secondary anti-biotin antibody bound to the biotin analog moiety and linked to a cell separation means. The complex is separated from the heterogeneous cell suspension, then incubated with a competitive compound, preferably authentic biotin, for which the secondary antibody has a higher affinity than it has for the biotin analog. The competitive compound displaces the biotin analog moiety from the binding site of the secondary antibody, thus releasing the target cells from the complex. The cell separation means may then be separated from the target cells. Another method involves the formation within the heterogeneous cell suspension of a complex formed by the target cell bound to a primary antibody linked to a biotin analog moiety and a form of avidin, which is bound to the biotin analog moiety. The complex is separated from the heterogeneous cell suspension and then incubated with a competitive compound, preferably authentic biotin, for which avidin has a higher affinity than it has for the biotin analog. The competitive compound displaces the biotin analog moiety from the avidin binding site, thus releasing the target cells from the complex. The avidin may then be separated from the target cells. The invention also provides compositions of matter which are intermediate complexes in the above methods. One intermediate complex comprises a cell separation means bound to an anti-biotin antibody, which in turn is bound to a biotin analog moiety covalently linked to a target cell binding protein. Another intermediate complex comprises avidin bound to a biotin analog moiety covalently linked to a target cell binding protein.
Abstract:
The invention provides a nonenzymic method for the release of cells which have been selected from a heterogeneous cell suspension by antibody-mediated binding to beads or other solid support. The method entails forming within the cell suspension a complex comprising the solid support linked to a primary monoclonal antibody, which in turn is bound to a cell surface antigen on the target cells. The complex is separated from the cell suspension, and then contacted with a specific peptide which binds to the primary antibody, displacing the antibody from the cell surface antigen, thereby releasing the target cell from the complex. The invention also provides methods for positive/negative cell selection wherein target cells having a first antigen are selected from a heterogeneous cell suspension containing undesired cells having a second antigen.